JPMorgan Chase & Co. bought a new stake in Care.com Inc (NYSE:CRCM) in the third quarter, HoldingsChannel.com reports. The firm bought 92,148 shares of the information services provider’s stock, valued at approximately $1,457,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Wells Fargo & Company MN raised its stake in Care.com by 13.8% during the second quarter. Wells Fargo & Company MN now owns 11,711 shares of the information services provider’s stock valued at $176,000 after buying an additional 1,420 shares during the last quarter. Teachers Advisors LLC raised its stake in Care.com by 2.3% during the second quarter. Teachers Advisors LLC now owns 87,415 shares of the information services provider’s stock valued at $1,320,000 after buying an additional 1,929 shares during the last quarter. Bank of New York Mellon Corp raised its stake in Care.com by 3.4% during the second quarter. Bank of New York Mellon Corp now owns 75,513 shares of the information services provider’s stock valued at $1,140,000 after buying an additional 2,491 shares during the last quarter. Parametric Portfolio Associates LLC raised its stake in Care.com by 14.8% during the second quarter. Parametric Portfolio Associates LLC now owns 26,724 shares of the information services provider’s stock valued at $404,000 after buying an additional 3,454 shares during the last quarter. Finally, Strs Ohio raised its stake in Care.com by 8.6% during the third quarter. Strs Ohio now owns 44,400 shares of the information services provider’s stock valued at $705,000 after buying an additional 3,500 shares during the last quarter. Institutional investors own 74.29% of the company’s stock.

Shares of Care.com Inc (CRCM) opened at $19.23 on Thursday. The company has a market capitalization of $578.50, a price-to-earnings ratio of 240.38, a price-to-earnings-growth ratio of 2.89 and a beta of 1.05. Care.com Inc has a fifty-two week low of $8.05 and a fifty-two week high of $20.88.

Care.com (NYSE:CRCM) last posted its earnings results on Thursday, November 2nd. The information services provider reported $0.18 EPS for the quarter, topping the Zacks’ consensus estimate of $0.08 by $0.10. The business had revenue of $44.50 million during the quarter, compared to analyst estimates of $44.22 million. Care.com had a return on equity of 17.27% and a net margin of 4.46%. The company’s quarterly revenue was up 9.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.02 EPS. equities analysts anticipate that Care.com Inc will post 0.31 earnings per share for the current year.

In other Care.com news, General Counsel Diane Musi sold 15,000 shares of Care.com stock in a transaction on Wednesday, January 3rd. The stock was sold at an average price of $18.86, for a total value of $282,900.00. Following the completion of the sale, the general counsel now owns 51,888 shares of the company’s stock, valued at approximately $978,607.68. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider David Krupinski sold 1,806 shares of Care.com stock in a transaction on Thursday, January 4th. The stock was sold at an average price of $19.12, for a total value of $34,530.72. Following the completion of the sale, the insider now directly owns 181,108 shares of the company’s stock, valued at approximately $3,462,784.96. The disclosure for this sale can be found here. In the last three months, insiders sold 253,054 shares of company stock valued at $4,487,989. Corporate insiders own 35.90% of the company’s stock.

A number of research analysts have issued reports on CRCM shares. BidaskClub cut Care.com from a “sell” rating to a “strong sell” rating in a research note on Friday, September 22nd. Zacks Investment Research upgraded Care.com from a “hold” rating to a “buy” rating and set a $18.00 price objective for the company in a research note on Monday, October 9th. Finally, Roth Capital upgraded Care.com from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $14.00 to $18.00 in a research note on Thursday, November 2nd. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Care.com presently has a consensus rating of “Buy” and a consensus target price of $17.67.

ILLEGAL ACTIVITY NOTICE: “JPMorgan Chase & Co. Buys New Position in Care.com Inc (CRCM)” was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://www.watchlistnews.com/jpmorgan-chase-co-buys-new-position-in-care-com-inc-crcm/1802502.html.

Care.com Profile

Care.com, Inc is an online marketplace for finding and managing family care. As of December 31, 2016, the Company had 22.8 million members, including 12.9 million families and 9.9 million caregivers, spanning 19 countries. Its consumer matching solutions allow families to search for, qualify, vet, connect with and select caregivers.

Want to see what other hedge funds are holding CRCM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Care.com Inc (NYSE:CRCM).

Institutional Ownership by Quarter for Care.com (NYSE:CRCM)

Receive News & Ratings for Care.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Care.com and related companies with Analyst Ratings Network's FREE daily email newsletter.